First Round Capital
Listed as “Ossium Health”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Ossium Health develops cell therapies derived from bone marrow.
Ossium Health makes bone marrow cell therapies being evaluated for blood diseases, organ rejection and musculoskeletal defects.
Healthcare
Category source ↗Checked
SF Bay Area
Location source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Ossium Health”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.